Peptide record

TPDB13566

Figainin 2 Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
28 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB13566
Figainin 2
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia CancerPPD 2.0 dbACP Antifungipept CAFPdb dbAMP dbAMP 3.0 AI4AVP DRAVP 2.0 PD_Hemolysis ToxinPred 3.0
standard
No
A 28-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, Peptipedia, CancerPPD 2.0, and other sources, with an available 3D structural model.
Sequence
FLGAILKIGHALAKTVLPMVTNAFKPKQ
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C142H236N36O33S1
RDCESWY
ALK
3007.72
11.00
5
0
15
+4
-0.39
0.575
118.57
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
4
Residue Composition
number
4
A
0
R
1
N
0
D
0
C
0
E
1
Q
2
G
1
H
2
I
4
L
4
K
1
M
2
F
2
P
0
S
2
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 4 R: 0 N: 1 D: 0 C: 0 E: 0 Q: 1 G: 2 H: 1 I: 2 L: 4 K: 4 M: 1 F: 2 P: 2 S: 0 T: 2 W: 0 Y: 0 V: 2
Chemical Descriptors
28 reviewed residue count
C142H236N36O33S1 sequence-only estimate (linear, free termini)
3007.72 sequence-only estimate (linear, free termini)
11.00 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
-0.39 sequence-only estimate (linear, free termini)
0.575 sequence-only estimate (linear, free termini)
Free Activity
L Activity
Linear Activity
Free Activity
Antimicrobial and Anticancer Activity
Boana raniceps Activity
Evidence Records 24 records
Evidence 1 Activity

Activity

MIC
Antibacterial
4-8 µM

Target

E. casseliflavus ATCC 700327

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
t Gram+ bacteria S. aureus ATCC 25923, E. faecalis ATCC 29212, S. epidermidis ATCC 12228, E. casseliflavus ATCC 700327 (MIC 4-8 uM). Gram- E. coli ATCC 25922, K. pneumoniae ATCC 13883 (MIC 8 uM), K. pneumoniae carbapanema
Evidence 2 Activity

Activity

MIC
Antibacterial
8 µM

Target

Klebsiella pneumoniae ATCC 13883

Source & Reference

dbAMP

Other

dermidis ATCC 12228, E. casseliflavus ATCC 700327 (MIC 4-8 uM). Gram- E. coli ATCC 25922, K. pneumoniae ATCC 13883 (MIC 8 uM), K. pneumoniae carbapanemase (KPC) MR, P. aeruginosa ATCC 27853 (MIC 16-32 uM). Antiparas
Evidence 3 Activity

Activity

MIC
Antibacterial
16-32 µM

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

dbAMP

Other

li ATCC 25922, K. pneumoniae ATCC 13883 (MIC 8 uM), K. pneumoniae carbapanemase (KPC) MR, P. aeruginosa ATCC 27853 (MIC 16-32 uM). Antiparasitic against Trypanosoma epimastigotes form T. cruzi (MIC 6.3 uM). The peptide
Evidence 4 Activity

Activity

MIC
Antibacterial
6.3 µM

Target

T. cruzi

Source & Reference

dbAMP

Other

eruginosa ATCC 27853 (MIC 16-32 uM). Antiparasitic against Trypanosoma epimastigotes form T. cruzi (MIC 6.3 uM). The peptide also inhibits cancer cell proliferation (IC50 = 12.8 uM for B16F10 murine me
Evidence 5 Activity

Activity

IC50
IC50 = 12.8 µM
Anticancer
12.8 µM

Target

Skin Cancer
B16-F10
Skin

Assay & Model

MTT assay
24-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2020

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation. dbAMP 3.0 classified as Anticancer under the disease-associated peptide function classes.
Evidence 6 Activity

Activity

IC50
IC50= 15.3 µM
Anticancer
15.3 µM

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT assay
24-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2020
Evidence 7 Activity

Activity

MIC
Antifungal
4-8 µM

Target

E. casseliflavus ATCC 700327

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
t Gram+ bacteria S. aureus ATCC 25923, E. faecalis ATCC 29212, S. epidermidis ATCC 12228, E. casseliflavus ATCC 700327 (MIC 4-8 uM). Gram- E. coli ATCC 25922, K. pneumoniae ATCC 13883 (MIC 8 uM), K. pneumoniae carbapanema
Evidence 8 Activity

Activity

MIC
Antifungal
8 µM

Target

Klebsiella pneumoniae ATCC 13883

Source & Reference

dbAMP CAFPdb Antifungipept

Other

dermidis ATCC 12228, E. casseliflavus ATCC 700327 (MIC 4-8 uM). Gram- E. coli ATCC 25922, K. pneumoniae ATCC 13883 (MIC 8 uM), K. pneumoniae carbapanemase (KPC) MR, P. aeruginosa ATCC 27853 (MIC 16-32 uM). Antiparas
Evidence 9 Activity

Activity

MIC
Antifungal
16-32 µM

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

dbAMP CAFPdb Antifungipept

Other

li ATCC 25922, K. pneumoniae ATCC 13883 (MIC 8 uM), K. pneumoniae carbapanemase (KPC) MR, P. aeruginosa ATCC 27853 (MIC 16-32 uM). Antiparasitic against Trypanosoma epimastigotes form T. cruzi (MIC 6.3 uM). The peptide
Evidence 10 Activity

Activity

MIC
Antifungal
6.3 µM

Target

T. cruzi

Source & Reference

dbAMP CAFPdb Antifungipept

Other

eruginosa ATCC 27853 (MIC 16-32 uM). Antiparasitic against Trypanosoma epimastigotes form T. cruzi (MIC 6.3 uM). The peptide also inhibits cancer cell proliferation (IC50 = 12.8 uM for B16F10 murine me
Evidence 11 Activity

Activity

MIC
Antiparasitic
4-8 µM

Target

E. casseliflavus ATCC 700327

Source & Reference

dbAMP 3.0

Other

Source Activity Label Source Definition
Antiparasitic
dbAMP 3.0 classified under the Anti-parasitic function class.
t Gram+ bacteria S. aureus ATCC 25923, E. faecalis ATCC 29212, S. epidermidis ATCC 12228, E. casseliflavus ATCC 700327 (MIC 4-8 uM). Gram- E. coli ATCC 25922, K. pneumoniae ATCC 13883 (MIC 8 uM), K. pneumoniae carbapanema
Evidence 12 Activity

Activity

MIC
Antiparasitic
8 µM

Target

Klebsiella pneumoniae ATCC 13883

Source & Reference

dbAMP 3.0

Other

dermidis ATCC 12228, E. casseliflavus ATCC 700327 (MIC 4-8 uM). Gram- E. coli ATCC 25922, K. pneumoniae ATCC 13883 (MIC 8 uM), K. pneumoniae carbapanemase (KPC) MR, P. aeruginosa ATCC 27853 (MIC 16-32 uM). Antiparas
Evidence 13 Activity

Activity

MIC
Antiparasitic
16-32 µM

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

dbAMP 3.0

Other

li ATCC 25922, K. pneumoniae ATCC 13883 (MIC 8 uM), K. pneumoniae carbapanemase (KPC) MR, P. aeruginosa ATCC 27853 (MIC 16-32 uM). Antiparasitic against Trypanosoma epimastigotes form T. cruzi (MIC 6.3 uM). The peptide
Evidence 14 Activity

Activity

MIC
Antiparasitic
6.3 µM

Target

T. cruzi

Source & Reference

dbAMP 3.0

Other

eruginosa ATCC 27853 (MIC 16-32 uM). Antiparasitic against Trypanosoma epimastigotes form T. cruzi (MIC 6.3 uM). The peptide also inhibits cancer cell proliferation (IC50 = 12.8 uM for B16F10 murine me
Evidence 15 Activity

Activity

MIC
Antiviral
4-8 µM

Target

E. casseliflavus ATCC 700327

Source & Reference

dbAMP 3.0 DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
dbAMP 3.0 classified under the Anti-viral function class.
t Gram+ bacteria S. aureus ATCC 25923, E. faecalis ATCC 29212, S. epidermidis ATCC 12228, E. casseliflavus ATCC 700327 (MIC 4-8 uM). Gram- E. coli ATCC 25922, K. pneumoniae ATCC 13883 (MIC 8 uM), K. pneumoniae carbapanema
Evidence 16 Activity

Activity

MIC
Antiviral
8 µM

Target

Klebsiella pneumoniae ATCC 13883

Source & Reference

dbAMP 3.0 DRAVP 2.0

Other

dermidis ATCC 12228, E. casseliflavus ATCC 700327 (MIC 4-8 uM). Gram- E. coli ATCC 25922, K. pneumoniae ATCC 13883 (MIC 8 uM), K. pneumoniae carbapanemase (KPC) MR, P. aeruginosa ATCC 27853 (MIC 16-32 uM). Antiparas
Evidence 17 Activity

Activity

MIC
Antiviral
16-32 µM

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

dbAMP 3.0 DRAVP 2.0

Other

li ATCC 25922, K. pneumoniae ATCC 13883 (MIC 8 uM), K. pneumoniae carbapanemase (KPC) MR, P. aeruginosa ATCC 27853 (MIC 16-32 uM). Antiparasitic against Trypanosoma epimastigotes form T. cruzi (MIC 6.3 uM). The peptide
Evidence 18 Activity

Activity

MIC
Antiviral
6.3 µM

Target

T. cruzi

Source & Reference

dbAMP 3.0 DRAVP 2.0

Other

eruginosa ATCC 27853 (MIC 16-32 uM). Antiparasitic against Trypanosoma epimastigotes form T. cruzi (MIC 6.3 uM). The peptide also inhibits cancer cell proliferation (IC50 = 12.8 uM for B16F10 murine me
Evidence 19 Activity

Activity

9% Hemolysis
Toxicity
16 µM
Hemolytic Cytotoxic
9% Hemolysis | 16 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Biological Properties of a Novel Multifunctional Host Defense Peptide from the Skin Secretion of the Chaco Tree Frog, Boana raniceps. | Biomolecules | 2020
Evidence 20 Activity

Activity

23% Hemolysis
Toxicity
32 µM
Hemolytic Cytotoxic
23% Hemolysis | 32 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Biological Properties of a Novel Multifunctional Host Defense Peptide from the Skin Secretion of the Chaco Tree Frog, Boana raniceps. | Biomolecules | 2020
Evidence 21 Activity

Activity

50% Hemolysis
Toxicity
48.9 µM
Hemolytic Cytotoxic
50% Hemolysis | 48.9 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Biological Properties of a Novel Multifunctional Host Defense Peptide from the Skin Secretion of the Chaco Tree Frog, Boana raniceps. | Biomolecules | 2020
Evidence 22 Activity

Activity

22% Hemolysis
Toxicity
80 µg/mL
Hemolytic Cytotoxic
22% Hemolysis | 80 | µg/mL | target cell: Mouse erythrocytes

Target

Mouse erythrocytes

Source & Reference

NA
DBAASP
All-hydrocarbon stapling enables improvement of antimicrobial activity and proteolytic stability of peptide Figainin 2. | J Pept Sci | 2024
Evidence 23 Activity

Activity

Toxicity
Cytotoxic
Cytotoxicity: [Ref.32443921]No cytotoxicity against noninfected Huh7 cells at concentrations as high as 25 µM.

Source & Reference

NA
DRAMP
Biomolecules. 2020 May 20 10(5):790.
Evidence 24 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis